+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Controlled Release Drug Delivery Market Report 2026 - Product Thumbnail Image

Controlled Release Drug Delivery Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Hepatitis C Market Report 2026 - Product Thumbnail Image

Hepatitis C Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Digital Biomarkers Market - Global Outlook & Forecast 2024-2029 - Product Thumbnail Image

Digital Biomarkers Market - Global Outlook & Forecast 2024-2029

  • Report
  • February 2024
  • 352 Pages
  • Global
From
From
From
From
From
Dementia Treatment - Global Strategic Business Report - Product Thumbnail Image

Dementia Treatment - Global Strategic Business Report

  • Report
  • July 2026
  • 204 Pages
  • Global
From
Facial Palsy - Global Strategic Business Report - Product Thumbnail Image

Facial Palsy - Global Strategic Business Report

  • Report
  • July 2026
  • 367 Pages
  • Global
From
Blarcamesine Market - Global Strategic Business Report - Product Thumbnail Image

Blarcamesine Market - Global Strategic Business Report

  • Report
  • July 2026
  • 370 Pages
  • Global
From
From
From
From
From
From
Loading Indicator